China approved a shot co-developed by AstraZeneca Plc and Sanofi to ward off respiratory syncytial virus in a broad swath of infants, a first in the nation to thwart the highly contagious and potentially fatal infection. The National Medical Products Administration cleared the long-acting monoclonal antibody Beyfortus to prevent RSV infections in newborns, Astra said […]